American Endowment Foundation - 31 Dec 2024 SCHEDULE 13G/A Report for Cyclerion Therapeutics Inc. Common Stock, no par value (CYCN)

Filing Manager: American Endowment Foundation
Reporting Manager: American Endowment Foundation
Security: Cyclerion Therapeutics Inc. Common Stock, no par value
Symbol: CYCN
Shares outstanding: 2,709,287 shares
Disclosed Ownership: 133,026 shares
Ownership: 4.9%
Form type: SCHEDULE 13G/A
Filing time: 12 Feb 2025, 13:25:51 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
American Endowment Foundation	4.9%	133,026	0	133,026	/s/ Michele L. Hoza	Michele L. Hoza, General Counsel